P3 Health Partners Reaffirms Guidance For 2022 and Announces Guidance For 2023Business Wire • 01/11/23
P3 Health Partners to Present at the 41st Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/03/23
P3 Health Partners Provides Third-Quarter and Year-to-Date 2022 Financial ResultsBusiness Wire • 11/14/22
P3 Health Partners Announces Participation in Credit Suisse Healthcare ConferenceBusiness Wire • 11/02/22
P3 Health Partners Announces Nasdaq's Confirmation that it has Regained Compliance with Listing RequirementsBusiness Wire • 10/27/22
P3 Health Partners Provides Second-Quarter and Year-to-Date 2022 Financial Results; Increases 2022 Revenue OutlookGlobeNewsWire • 10/20/22
P3 Health Partners Announces Chief Financial Officer Transition Appoints Erin Darakjian as Interim CFOGlobeNewsWire • 10/20/22
P3 Health Partners Announces Receipt of Nasdaq Notice of Delisting and Intention to AppealBusiness Wire • 10/04/22
P3 Health Partners CEO Dr. Sherif Abdou to Speak at Nephron 2nd Annual Physician Enablement SymposiumBusiness Wire • 09/22/22
P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic ReportGlobeNewsWire • 08/19/22
Oregon State Athletics, P3 Health Partners Oregon Announce Multi-Year RelationshipGlobeNewsWire • 07/11/22